arXiv Computer Vision
Seeing Beyond the Lesion: Disease Recognition from Reactive CNS Tissue
Read the original on arXiv Computer Vision →The Flow has not summarised this story yet — read it at arXiv Computer Vision.
Related stories
Hugging Face Trending Papers
2d ago
Seeing Beyond the Lesion: Disease Recognition from Reactive CNS Tissue
Sampling error yields exclusively reactive, non-lesional brain parenchyma in a significant proportion of intracranial biopsies, leaving the underlying disease undiagnosed. We benchmark four pathology...
arXiv AI
Aug 7
Big, Bright, or Invisible: A Frozen-Feature Benchmark of 3D CT Foundation Models
arXiv:2608. 05960v1 Announce Type: cross Abstract: Routine CT interpretation is inherently comprehensive, capturing incidental findings across the entire scan volume.
arXiv AI
Jun 12
BrainDINO: A Brain MRI Foundation Model for Generalizable Clinical Representation Learning
arXiv:2604. 27277v3 Announce Type: replace-cross Abstract: Brain MRI underpins a wide range of neuroscientific and clinical applications, yet most learning-based methods remain task-specific and require substantial labeled data.
arXiv AI
Aug 14
A Distributional Robustness Margin For Pathology Foundation Models
arXiv:2607. 25497v2 Announce Type: replace-cross Abstract: Pathology foundation models encode non-biological variation introduced by tissue preparation, staining and scanning, enabling shortcut learning that undermines generalisation across institutions.
arXiv AI
Jun 9
Comparative evaluation of training strategies using partially labelled datasets for segmentation of white matter hyperintensities and stroke lesions in FLAIR MRI
arXiv:2601. 20503v2 Announce Type: replace-cross Abstract: White matter hyperintensities (WMH) and ischaemic stroke lesions (ISL) are key imaging biomarkers of cerebral small vessel disease (SVD) detectable on magnetic resonance imaging (MRI).
arXiv AI
Jul 29
Beyond Counts: A Distributional Robustness Margin For Pathology Foundation Models
arXiv:2607. 25497v1 Announce Type: cross Abstract: Pathology foundation models are approaching clinical deployment, yet remain vulnerable to systematic non-biological variation across centres.